A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects
Clinical trial NCT03844906 · COMPLETED
Trial details
- NCT number
- NCT03844906
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2019-03-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.